Antiviral treatment for the control of pandemic influenza: Some logistical constraints

Journal of the Royal Society Interface

Volumn 5, Issue 22, 2008, Pages 545-553

  Arinaminpathy, N ^a   McLean, A R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antiviral treatment; Influenza; Mathematical modelling; Pandemic

Indexed keywords

MATHEMATICAL MODELS; PATIENT TREATMENT;

ANTIVIRAL TREATMENT; INFLUENZA; PANDEMIC;

DISEASES;

ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR;

ARTICLE; DISEASE CONTROL; DRUG EFFICACY; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFLUENZA; MATHEMATICAL MODEL; PANDEMIC; PREVALENCE; RISK FACTOR; VIRUS VIRULENCE;

EID: 40749151561     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2007.1152     Document Type: Article

References (25)

1. Arino, J., Brauer, F., van den Driessche, P., Watmough, J. & Wu, J. 2006 Simple models for containment of a pandemic. J. R. Soc. Interface 3, 453-457. (doi:10.1098/rsif.2006.0112)
2. Barnes, B., Glass, K. & Becker, N. G. In press. The role of health care workers and antiviral drugs in the control of pandemic influenza. Math. Biosci. (doi:10.1016/j.mbs.2007.02.008).
3. Beigel, J. H. et al. 2005 Avian influenza A (H5N1) in humans. N. Engl. J. Med. 353, 1374-1385. (doi:10.1056/NEJMra052211)
4. Chowell, G., Ammon, C. E., Hengartner, N. W. & Hyman, J. M. 2006 Transmission dynamics of the great influenza pandemic of 1918 in Geneva Switzerland: assessing the effects of hypothetical interventions. J. Theor. Biol. 241, 193-204. (doi:10.1016/j.jtbi.2005.11.026)
5. Chowell, G., Nishiura, H. & Bettencourt, L. M. A. 2007 Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. J. R. Soc. Interface 4, 155-166. (doi:10.1098/rsif.2006.0161)
6. Colizza, V., Barrat, A., Barthelemy, M., Valleron, A. J. & Vespignani, A. 2007 Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions. PLoS Med. 4, e13. (doi:10.1371/journal.pmed.0040013)
7. Couch, R. B., Douglas Jr, R. G., Fedson, D. S. & Kasel, J. A. 1971 Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J. Infect. Dis. 124, 473-480.
8. De Jong, M. D. et al. 2005 Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353, 2667-2672. (doi:10.1056/NEJMoa054512)
9. Fedson, D. S. 2003 Pandemic influenza and the global vaccine supply. Clin. Infect. Dis. 36, 1552-1561. (doi:10.1086/375056)
10. Ferguson, N. M., Cummings, D. A., Cauchemez, S., Fraser, C., Riley, S., Meeyai, A., Iamsirithaworn, S. & Burke, D. S. 2005 Strategies for containing en emerging influenza pandemic in southeast Asia. Nature 437, 209-214. (doi:10.1038/nature04017)
11. Flahault, A., Vergu, E., Coudeville, L. & Grais, R. F. 2006 Strategies for containing a global influenza pandemic. Vaccine 24, 6751-6755. (doi:10.1016/j.vaccine.2006.05.079)
12. Gani, R., Hughes, H., Fleming, D., Griffin, T., Medlock, J. & Leach, S. 2005 Potential impact of antiviral drug use during influenza pandemic. Emerg. Infect. Dis. 11, 1355-1362.
13. Kermack, W. O. & McKendrick, A. G. 1927 A contribution to the mathematical theory of epidemics. Proc. R. Soc. A 115, 700-721. (doi:10.1098/rspa.1927.0118)
14. Li, K. S. et al. 2004 Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430, 209-213. (doi:10.1038/nature02746)
15. Lipsitch, M., Cohen, T., Murray, M. & Levin, B. 2007 Antiviral resistance and the control of pandemic influenza. PLoS Med. 4, e15. (doi:10.1371/journal.pmed.0040015)
16. Longini Jr, I. M., Nizam, A., Xu, S., Ungchusak, K., Hanshaoworakul, W., Cummings, D. A. T. & Halloran, M. E. 2005 Containing pandemic influenza at the source. Science 309, 1083-1087. (doi:10.1126/science.1115717)
17. McCaw, J. M. & McVernon, J. In press. Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. Math. Biosci. (doi:10.1016/j.mbs.2007.02.003).
18. Mills, C. E., Robins, J. M. & Lipsitch, M. 2004 Transmissibility of 1918 pandemic influenza. Nature 432, 904-906. (doi:10.1038/ nature03063)
19. Murray, J. D. 1989 Mathematical biology. Berlin, Germany: Springer.
20. Treanor, J. et al. 2000 Efficacy and safety of the oral neuraminidase inhibitor Oseltamivir in treating acute influenza. JAMA 283, 1016-1024. (doi:10.1001/jama.283.8.1016)
21. UK Health Departments 2005 Pandemic flu - UK influenza pandemic contingency plan. See. http://www.dh.gov.uk/assetRoot/04/12/17/44/04121744. pdf.
22. US Department of Health and Human Services 2005 HHS pandemic influenza plan. See. http://www.hhs.gov/pandemicflu/plan/pdf/ HHSPandemicInfluenzaPlan.pdf.
23. van den Driessche, P. & Watmough, J. 2002 Reproduction numbers and sub-threshold endemic equilibris for compartmental models of disease transmission. Math. Biosci. 180, 29-48. (doi:10.1016/S0025- 5564(02)00108-6)
24. Ward, P., Small, I., Smith, J., Suter, P. & Dutkowski, R. 2005 Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J. Antimicrob. Chemother. 55(Suppl. S1), i5-i21. (doi:10.1093/jac/dki018)
25. Webby, R. J. & Webster, R. G. 2003 Are we ready for pandemic influenza? Science 302, 1519-1522. (doi:10.1126/science.1090350)